User profiles for Y. Kanno

Yoshihiko Kanno

- Verified email at tokyo-med.ac.jp - Cited by 8208

Yasuko Kanno

- Verified email at bu.edu - Cited by 5962

The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

…, S Ito, Y Iwashima, H Kai, K Kamide, Y Kanno… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature reviews Drug …, 2017 - nature.com
The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts
to target their associated signalling pathways. Janus kinases (JAKs) are essential signalling …

Mechanisms and consequences of Jak–STAT signaling in the immune system

AV Villarino, Y Kanno, JJ O'Shea - Nature immunology, 2017 - nature.com
Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal
transducer and activator of transcription') family constitute a rapid membrane-to-nucleus …

Generation of pathogenic TH17 cells in the absence of TGF-β signalling

…, N Bouladoux, JR Grainger, Q Chen, Y Kanno… - Nature, 2010 - nature.com
CD4 + T-helper cells that selectively produce interleukin (IL)-17 (T H 17), are critical for host
defence and autoimmunity 1 , 2 , 3 , 4 . Although crucial for T H 17 cells in vivo 5 , 6 , IL-23 …

[HTML][HTML] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an …

…, RR Holman, Y Imai, M Ishii, S Julius, Y Kanno… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …

[HTML][HTML] Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

A Laurence, CM Tato, TS Davidson, Y Kanno, Z Chen… - Immunity, 2007 - cell.com
Recent work has identified a new subset of effector T cells that produces interleukin (IL)-17
known as T helper 17 (Th17) cells, which is involved in the pathophysiology of inflammatory …

Imagined communities and educational possibilities: Introduction

Y Kanno, B Norton - Journal of language, identity, and education, 2003 - Taylor & Francis
… Societal constraints on an individual’s capacity to imagine a different future come out even
more explicitly in Kanno’s and Blackledge’s studies. Kanno’s research demonstrates how …

[PDF][PDF] Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells

…, L Wei, J Zhu, C Zang, J Hu-Li, Z Yao, K Cui, Y Kanno… - Immunity, 2009 - cell.com
Multipotential naive CD4 + T cells differentiate into distinct lineages including T helper 1 (Th1),
Th2, Th17, and inducible T regulatory (iTreg) cells. The remarkable diversity of CD4 + T …

Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

…, A Laurence, AF Freeman, BJ Hill, KM Elias, Y Kanno… - Nature, 2008 - nature.com
The autosomal dominant hyper-IgE syndrome (HIES, ‘Job’s syndrome’) is characterized by
recurrent and often severe pulmonary infections, pneumatoceles, eczema, staphylococcal …

The JAK-STAT pathway at 30: Much learned, much more to do

RL Philips, Y Wang, HJ Cheon, Y Kanno, M Gadina… - Cell, 2022 - cell.com
The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT)
pathway arose from investigations of how cells respond to interferons (IFNs), revealing a …